In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer

Breast Cancer

Volumn 9, Issue 1, 2002, Pages 39-42

  Takei, Hiroyuki ^a,b   Lee, Eun Sook ^a,c   Craig Jordan, V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b GUNMA UNIVERSITY   (Japan)

^c National Cancer Center   (South Korea)

Author keywords

Angiogenesis; Breast cancer; ICI182,780; Tamoxifen; Vascular endothelial growth factor

Indexed keywords

4 HYDROXYTAMOXIFEN; 4-HYDROXYTAMOXIFEN; ANGIOGENESIS INHIBITOR; ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG DERIVATIVE; ENDOTHELIAL CELL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; LYMPHOKINE; TAMOXIFEN; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; BREAST TUMOR; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; METABOLISM; NEOPLASM;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LYMPHOKINES; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036051735     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967545     Document Type: Article

References (18)

1. Folkman J: What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 82:4-6, 1990. (Pubitemid 20020880)
2. Nakamura J, Savinov A, Lu Q, et al: Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz (a) anthracene-induced rat mammary tumors. Endocrinology 137:5589-5596, 1996. (Pubitemid 26423128)
3. Haran EF, Maretzek AJ, Goldberg I, et al: Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 54:5511-5514, 1994. (Pubitemid 24346235)
4. Evans SM, Koch CJ, Laughlin KM, et al: Tamoxifen induces hypoxia in MCF-7 xenografts. Cancer Res 57:5155-5161, 1997. (Pubitemid 27498135)
5. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91, 1996. (Pubitemid 26008141)
6. Shweiki D, Itin A, Softer D, et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992.
7. Ruohola JK, Valve EM, Karkkainen MJ, et al: Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149:29-40, 1999. (Pubitemid 29236221)
8. Zhang HT, Craft P, Scott PA, et al: Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87:213-219, 1995.
9. Lee E-S, Horiguchi J, Liu H, et al: Regulation of angiogenesis in tamoxifen-stimulated breast tumors by the pure antiestrogen ICI 182, 780. Proceedings of AACR 41, 2000.
10. Pink JJ, Jordan VC: Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56:2321-2330, 1996. (Pubitemid 26154081)
11. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352, 1980. (Pubitemid 10115803)
12. Hyder SM, Nawaz Z, Chiappetta C, et al: Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60:3183-3190, 2000. (Pubitemid 30407915)
13. Coezy E, Borgna JL, Rochefort H: Tamoxifen and metabolites in MCF7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 42:317-323, 1982. (Pubitemid 12207285)
14. Jordan VC, Collins MM, Rowsby L, et al: A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J Endocrinol 75:305-316, 1977. (Pubitemid 8219148)
15. Reddel RR, Murphy LC, Sutherland RL: Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res 43:4618-4624, 1983. (Pubitemid 13014191)
16. Reddel RR, Murphy LC, Hall RE, et al: Differential sensitivity of human cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res 45:1525-1531, 1985. (Pubitemid 15079098)
17. Robinson SP, Jordan VC: Metabolism of steroid-modifying anticancer agents. Parmacol Ther 36:41-103, 1988. (Pubitemid 18001622)
18. Howell A, De Friend D, Robertson J, et al: Response to a specific antiestrogen (10182, 780) in tamoxifen-resistant breast cancer. Lancet 345:29-30, 1995.